The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.1075
Bid: 0.105
Ask: 0.11
Change: -0.0025 (-2.27%)
Spread: 0.005 (4.762%)
Open: 0.11
High: 0.11
Low: 0.1025
Prev. Close: 0.11
SYN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

5 Dec 2016 07:00

RNS Number : 8898Q
Plastics Capital PLC
05 December 2016
 

5 December 2016

 

Plastics Capital plc

("Plastics Capital", the "Company" or the "Group")

 

Interim Results for the six months ended 30 September 2016

 

Plastics Capital (AIM: PLA) the niche plastics products manufacturer, announces the Company's unaudited interim results for the six months ended 30 September 2016, which are in line with management expectations.

 

Financial highlights

Six months ended

30 September 2016

£'000

Six months ended

30 September 2015

£'000

 

% Change

Revenue

27,771

24,489

+13.4%

EBITDA*

2,731

2,464

+10.8%

Profit before tax*

1,637

1,526

+7.3%

Earnings per share*+ (p)

4.3

4.0

+7.3%

Dividend per share (p)

1.46

1.46

0%

* excluding amortisation, exceptional costs, unrealised foreign exchange translation and derivative gains / losses and share-based incentive scheme charges

+ applying an expected tax charge of 6.5% and based on the weighted average number of shares in issue in the period.

 

Operational highlights

Strong organic revenue growth of 6.7% at constant currency

Industrial Division revenue up 19.2%, led by key accounts growth in bearings business

Films Division revenue up 9.2%, led by continued growth of Flexipol

Good initial contribution from Synpac Limited ("Synpac"), acquired July 2016

Significant investment in business development, new products and management

Underlying profitability remains strong

£1.3m invested in development and capacity expansion projects

Full benefit of post-Brexit sterling devaluation still to be felt

£6.3m of sales from won projects still to enter into production

 

Commenting on these results, Faisal Rahmatallah, Executive Chairman, said:

"I am pleased to report good growth across the Group. We continue to increase investment in business development, new products and additional capacity and capabilities. Order books are healthy and we anticipate a significant improvement in performance during the second half year which will benefit from the seasonal demand upswing and a full contribution from Synpac. The Board expects the Group to continue to perform in line with expectations for the rest of the financial year."

 

 

 

For further information, please contact:

 

Plastics Capital plc

Tel: 020 7978 0574

Faisal Rahmatallah, Executive Chairman

Nick Ball, Finance Director

Cenkos Securities

Tel: 020 7397 8900

(Nomad and joint broker)

Mark Connelly

Callum Davidson

Allenby Capital Limited

Tel: 020 3328 5656

(Joint broker)

David Hart

Katrina Perez

Walbrook PR Ltd

Tel: 020 7933 8780 or plastics@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Helen Cresswell

Mob: 07841 917 679

 

 

Notes to Editor

Plastics Capital is a niche manufacturer of specialist plastic products. Applications for these products vary widely and examples include:

Packaging for the food manufacturing and distribution - films, sacks and pouches

Steering columns and instrument control knobs in the automotive industry - plastic ball bearings

Hydraulic and industrial rubber hose manufacture - various types of plastic mandrel

Cardboard box manufacture - plastic creasing matrices

 

Plastics Capital's business model is based on understanding customers' problems in depth, and then developing and mass producing proprietary, technical solutions for these problems.

 

The business operates through two divisions, Films and Industrial, and has the majority of its production in six UK based factories, with a further three factories in Asia. Approximately 40% of its £55 million sales are made outside the UK to more than 80 countries.

 

Further information can be found on www.plasticscapital.com

 

 

 

Chairman's Statement

 

Financial Review

 

I am pleased to report that overall Group revenue increased by 13.4% over the same period last year. Revenue growth in H1 2016-17 was attributable to organic development, acquisition and foreign exchange movements and can be summarised as follows:

· Organic growth - 6.7%

· Acquisition - 3.8%

· Foreign Exchange - 2.9%

Following considerable investment in recent years in business development activities, it is particularly pleasing to report a significant upswing in organic growth.

 

Gross margins have strengthened to 32.0% in H1 16-17 from 30.7% in H1 15-16; two thirds of this improvement is due to foreign exchange movements and the remainder due to improving product mix. Ignoring foreign exchange and acquisitions our total gross profit has increased 10.8% for the period under review - slightly more than the organic revenue growth achieved. This speaks for the continuing competitiveness and value-add of our product portfolio.

 

We have increased expenditure on business development, engineering, technical service and management by a total of 18% in the period. The majority of this is due to our emphasis on organic growth, but some relates to the acquisition of Synpac and some to higher costs incurred in overseas subsidiaries due to sterling devaluation. These factors account for underlying EBITDA being up by only 10.8% in the half year, when more may be expected due to our operational gearing.

 

The positive impact of sterling weakness on the Group's profitability has been significant, and we expect will become more significant over the next year or two. Overall in the half year, the devaluation of sterling has contributed £0.2m to underlying EBITDA. If we had not been hedged for all our US dollar trading exposure, there would have been a further contribution to EBITDA of £0.3m during the half year. We must not allow the devaluation of sterling, which is a piece of good fortune, to make us complacent.

 

Also, due to our focus on organic growth, capital expenditure has increased to £1.9m for the half year, against £1.2m in the same period last year; approximately two thirds of this expenditure is related to additional capacity, of which 50% is for customer-specific projects that are already contracted. The half-yearly depreciation charge has consequently increased by 13%.

 

Interest cost has increased £0.1m as we refinanced in June 2016 with Barclays, increasing our facilities by £4m to enable us to carry out the Synpac acquisition and the capital expenditure mentioned above. Consequently, underlying profit before tax is up 7.3% on the same period in the prior year.

 

Our effective corporation tax rate is once again estimated to remain low at approximately 6.5% for the full year as we are entitled to significant capital allowances and the R&D tax credit. We believe our effective corporation tax rate will remain below 10% for the foreseeable future.

 

 

 

We have issued a further 296,450 shares during the half year as approximately 30% of our shareholders chose to take the end-of-year dividend in scrip rather than cash. Consequently underlying earnings per share has increased 7.3% from 4.0p to 4.3p.

 

Films Division

The Films Division accounted for approximately 55% of Group sales in the period under review including two and a half months of contribution from Synpac, which has performed in line with our expectations.

 

Flexipol has continued to perform well, increasing sales and maintaining margins during a period when there has been pressure on prices through the food manufacturing supply chain. Overhead costs have increased due to the sale and leaseback of the Flexipol facility in Haslingden, Lancashire, performed in the prior year and the full impact of employees joining during the prior year in sales and engineering roles.

 

Palagan is going through some important strategic and management changes designed to build competitiveness, which we feel has been slightly eroded over recent years. Specifically this has meant developing new higher strength films and converted products, new approaches to customer service and changes to the management team.

 

Synpac, which we acquired in July 2016, has brought some new opportunities to the Films Division. Its product portfolio fits well with Flexipol's, creating joint sales opportunities which we have already begun to exploit. In addition, some of Synpac's films, which have been imported from third parties for conversion into pouches at Synpac, can be made by both Flexipol and Palagan so improving overall margins within the Films Division.

 

Comparing H1 2016-17 with H1 2015-16 on a constant currency, like-or-like basis for the Films Division, including the equivalent contribution from Synpac in the prior year:

· Revenue is up 2.3%

· EBITDA is up 1%

 

Industrial Division

In the period under review, revenue in the Industrial Division, which accounted for approximately 45% of Group sales, were 18.6% up on the same period last year. 93% of sales in the Industrial Division were made outside the UK. Underlying gross margin, after adjusting for foreign exchange, has increased by 17.0%. Overheads have increased £0.3m, primarily due to sales, engineering and management resources hired in the prior year; this has reduced profit growth in the short term but will enable the Division to continue to grow henceforward.

 

Bearings business sales were up 25.6% in H1 16-17 compared to H1 15-16; ignoring currency movements the improvement was 16.2%. This performance has been due to previously reported new project wins flowing through into production, as well as the continued development of key accounts - we have had particular success in H1 16-17 in the automotive and ATM industries. The new business pipeline at BNL (projects already won but not yet in production or not yet at full production rate) has increased from £4.5 million at the end of FY15-16 to £5.3m at the end of H1 16-17. This business is expected to flow through over the next three to four years.

 

Creasing matrix revenues were up 12.1% in H1 16-17 compared to H1 15-16; ignoring currency movement the improvement was 10.2%. There has been some recovery in demand, particularly in emerging country end-markets, and our initiatives to establish a UK sales and distribution capability for die-making consumables and to introduce additional niche products have been very successful.

 

Our mandrel business has also performed well in H1 16-17 with sales up 12.7% on prior year; ignoring currency movement the improvement was 5.4%. New business won in FY 15-16 which has now flowed through has been the main reason for the increase in sales.

 

Comparing H1 2016-17 with H1 2015-16 on a constant currency, like-or-like basis for the Industrial Division:

· Revenue is up 12.2%

· EBITDA is up 4.8%

 

 

Growth & Investment

 

We are now one and a half years into our five year target to double annual EBITDA to £10.5m. This target excludes contributions from acquisitions requiring new equity to be raised. Having made a relatively slow start last year, I am pleased to say that we believe that momentum is building.

 

One important measure we track is the value of new business won that has not yet entered into production or has not reached full production levels - this measure is now standing at £6.30m, up from £4.8m at the end of FY16; after adjusting for currency movement the increase is still £0.7m in the six month period.

 

Growth necessitates investment; I wrote to shareholders in July 2016 to articulate the background to approximately £4m of investments available to us which we believe offer attractive returns. We have taken these forward as follows:

 

· Customer-specific projects - £0.6m has been invested in H1 16-17 into new injection moulding and automated assembly machines for two major projects in our bearings business. A further £0.3m of investment is still to be made. We still expect incremental annual sales of £2m to be achieved from these projects in due course.

· Capacity expansion - £0.5m has been invested in H1 16-17 into new capacity to alleviate capacity bottlenecks that we anticipated in three growth areas:

· At Flexipol we are increasing extrusion capacity by 33%. To this end, we have carried out building modifications ready to install a new blown-film extrusion line which we expect to be in place during Q4 FY 2017. £0.4m has been invested in H1 16-17 out of expected total project costs of £0.75m.

· At our mandrel business we are seeking to increase extrusion capacity by 30%. This is needed to capitalise on improving market conditions and on successful new business development over recent years. New extrusion lines have been ordered and additional adjoining factory space is being fitted out to enable this expansion to take place. To date, capital expenditure has been limited but we anticipate total costs of £0.3m to have been incurred by the current financial year end.

· Our bearings business will require 20% additional capacity in its Thai facility as more production is moved to this location. This project is pending.

· New product developments - We have invested £0.3m in new product development in H1 16-17. New products recently launched include a range of standard ball plastic ball bearings and a new high strength packaging film intended initially for the furniture industry. Other important product developments are in the pipeline and expenditure in this area will continue.

· Corporate activity - £0.3m has been invested in H1 16-17 in minority investments within our creasing matrix business. We acquired a 10% stake in Channel Creasing Matrix Inc. ("CCM") in May 2016 and have options in place to acquire a further 39% and, ultimately, 100%. CCM is the only manufacturer of creasing matrix in the US and also distributes a range of die-making consumables. For legacy reasons, it is the brand owner of the Channel brand of creasing matrix in the US, which is the brand we own everywhere else in the world. We expect to make further similar investments in due course.

In total we have invested £1.5m in expansion capital expenditure during H1, far surpassing the rate of re-investment in the business incurred previously. This underlines our commitment to achieve strong organic growth. Meanwhile, during the same period, maintenance capex has been £0.4m, which is slightly higher than normal.

 

 

Acquisitions

 

We completed the acquisition of Synpac, based in Hessle, Yorkshire, on 15th July for £3.1m, of which 10% is deferred for one year. Synpac converts packaging films into vacuum bags and pouches used in food manufacturing and distribution. As such it is complementary to Flexipol, who also manufacture a range of vacuum bags generally sold to larger customers. We are busy with integration activities and are delighted with the level of professionalism, expertise and loyalty we have found within the team at Synpac.

 

As regards further acquisitions, there are a number of good opportunities that have presented themselves in the last 3-6 months. We remain enthusiastic to add businesses that are complementary to our existing ones, and meet our other criteria in terms of size, profitability and cash flow. We are hopeful that we can bring one or more to fruition over the next 12-24 months.

 

 

Debt

 

We refinanced with Barclays in June 2016, increasing our facilities by £4m, principally to finance the Synpac acquisition. This, together with good cash flow, has enabled us to make the investments and acquisition described above. Net debt has consequently increased to £15.1m from £10.9m at the end of March 2016. Statutory net debt leverage has increased from 1.8 times to 2.3 times and in the next twelve months we expect will come down to 1.5- 2.0 times, which is the target we have set ourselves. Meanwhile, interest cover is very solid at 13.3 times.

 

 

Dividend

 

To assist with formulation of dividend policy, the Board has assessed how our internally generated free cash flow has been used in recent years. Following the financial crisis in FY2009-10, almost all our free cash flow was used to pay down debt. In FY2012-13, payments of dividends and reinvestment in the business started to increase at similar rates until in FY2015-16 roughly equal emphasis was given to paying down debt, paying dividends and reinvesting in the business. Because of the excellent organic growth opportunities we see, the Board now believes that our internally generated free cash flow should be allocated increasingly towards reinvestment in the business.

 

Reflecting this confidence in the growth potential of the business, the Company is pleased to announce that it intends to maintain the interim dividend at 1.46p (H1 2015-16: 1.46p), payable to shareholders on 1 February 2017. As with the final dividend announced in July 2016 we will be offering shareholders a scrip dividend alternative. This enables those who would rather see the Company retain cash and reinvest it, instead of paying it out in dividends, to do so by receiving new shares instead of cash. The record date for the dividend is 16 December 2016 and the associated ex-dividend date is 15 December 2016. The latest date to elect for the scrip dividend alternative is 18 January 2017. The Company will, on or before Friday 9 December, post to shareholders a letter containing additional information on the scrip dividend alternative and how shareholders may participate. At the same time, a copy of this letter will be available on the Company's website: www.plasticscapital.com.

 

 

Outlook

 

We have seen a healthy improvement in our order books over the autumn period and anticipate improved financial performance in the second half due to the seasonality that now applies to the Group. We also expect the pipeline of new business in our bearings business will enter into production at a more rapid rate than we have experienced in the recent past. We believe that our five year plan, the investments already under way and the associated management processes should continue to drive the business forward. The Board therefore remains confident about the future growth of the Group.

 

 

Faisal Rahmatallah

Executive Chairman

Plastics Capital plc

Unaudited Consolidated Income Statement

for the six months ended 30 September 2016 and the six months ended 30 September 2015

 

 

Before foreign exchange & exceptional items

Foreign exchange impact on derivatives

Exceptional items

Total

Before foreign exchange & exceptional items

Foreign exchange impact on derivatives

Exceptional items

Total

2016

2016

2016

2016

2015

2015

2015

2015

Note

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Revenue

27,771

-

-

27,771

24,489

-

-

24,489

Cost of sales

(18,586)

(308)

-

(18,894)

(16,827)

(142)

-

(16,969)

Gross profit

9,185

(308)

-

8,877

7,662

(142)

-

7,520

Distribution expenses

(1,376)

-

-

(1,376)

(1,280)

-

-

(1,280)

Administration expenses

(6,357)

-

(269)

(6,626)

(5,202)

-

(222)

(5,424)

Other income

36

-

-

36

15

-

-

15

Operating profit

1,488

(308)

(269)

911

1,195

(142)

(222)

831

Financial income

5

-

-

-

-

-

235

-

235

Finance expense

5

(399)

(1,240)

-

(1,639)

(305)

-

-

(305)

Net financing (costs) / income

(399)

(1,240)

-

(1,639)

(305)

235

-

(70)

(Loss) / profit before tax

1,089

(1,548)

(269)

(728)

890

93

(222)

761

Tax

6

(107)

-

-

(107)

(127)

-

-

(127)

(Loss) / profit for the period

982

(1,548)

(269)

(835)

763

93

(222)

634

Foreign exchange translation differences

(4)

-

-

(4)

(172)

-

-

(172)

 

Total comprehensive (loss) / income

978

(1,548)

(269)

(839)

591

93

(222)

462

Earnings per share

Basic

8

(0.2)p

1.8p

Diluted

8

(0.2)p

1.8p

 

 

Plastics Capital plc

Consolidated Income Statement (continued)

for the year ended 31 March 2016

 

 

Audited

Before foreign exchange & exceptional

items

Audited

Foreign exchange impact on derivatives

Audited

Exceptional items

Audited

Total

2016

2016

2016

2016

Note

£'000

£'000

£'000

£'000

Revenue

50,803

-

-

50,803

Cost of sales

(33,693)

(239)

-

(33,932)

Gross profit

17,710

(239)

-

16,871

Distribution expenses

(2,539)

-

-

(2,539)

Administration expenses

(12,168)

-

(360)

(12,528)

Other income

54

-

-

54

Operating profit

2,457

(239)

(360)

1,858

Financial expense

5

(722)

(38)

-

(760)

Net financing costs

(722)

(38)

-

(760)

Profit before tax

1,735

(277)

(360)

1,098

Tax

6

124

-

-

124

Profit for the period

1,859

(277)

(360)

1,222

Foreign exchange translation differences

5

-

-

5

Total comprehensive income

1,963

(277)

(360)

1,227

Earnings per share

Basic

8

3.5p

Diluted

8

3.4p

 

Plastics Capital plc

Consolidated Balance Sheets

 

Unaudited

As at

30

September

2016

 

Unaudited

As at

30

September

2015

 

Audited

As at

31

March

2016

£000

£000

£000

Non-current assets

Property, plant and equipment

9,382

7,784

8,130

Intangible assets

24,286

23,851

22,796

33,668

31,635

30,926

Current assets

Inventories

5,712

4,515

4,783

Trade and other receivables

12,556

11,539

11,945

Cash and cash equivalents

4,150

3,991

5,488

22,418

20,045

22,216

Total assets

56,086

51,680

53,142

Current liabilities

Interest-bearing loans and borrowings

5,810

5,798

8,067

Trade and other payables

9,872

8,665

9,315

Corporation tax liability

495

486

388

16,177

14,949

17,770

Non-current liabilities

Interest-bearing loans and borrowings

13,463

10,057

8,273

Other financial liabilities

1,307

83

415

Deferred tax liabilities

361

724

361

15,131

10,864

9,049

Total liabilities

31,308

25,813

26,819

Net assets

24,778

25,867

26,323

Equity attributable to equity holders of the parent

Share capital

356

353

353

Share premium

21,263

20,888

20,951

Reverse acquisition reserve

2,640

2,640

2,640

Translation reserve

652

462

639

Capital redemption reserve

-

(200)

-

Retained earnings

(133)

1,724

1,740

Total equity

24,778

25,867

26,323

 

 

 

Plastics Capital plc

Consolidated Cash Flow Statements

Unaudited

Six months

ended

30

September

2016

Unaudited

Six months

ended

30

September

2015

Audited

Year

ended

31

March

2016

£000

£000

£000

(Loss) / profit after tax for the period

(835)

634

 

1,222

Adjustments for:

 Income tax adjustment

107

127

(124)

 Depreciation, amortisation and impairment

1,551

1,411

2,948

 Financial income

-

(235)

-

 Financial expense

1,639

305

760

 Gain on disposal of plant, property and equipment

-

-

(74)

Changes in working capital:

 (Increase) in trade and other receivables

(25)

(399)

(806)

 (Increase) in inventories

(408)

(509)

(777)

 Increase / (Decrease) in trade and other payables

104

(123)

937

Cash generated from operations

2,133

1,211

4,487

Interest paid

(292)

(230)

(377)

Income tax paid

-

(190)

(275)

Net cash from operating activities

1,841

791

3,835

Cash flows from investing activities

Acquisition of subsidiary (net of cash acquired)

(2,470)

-

(300)

Acquisition of property, plant and equipment

(1,896)

(1,223)

(2,275)

Dividends received

-

14

35

Proceeds from disposal of plant, property and equipment

-

1,400

1,400

Development expenditure capitalised

(125)

(125)

(349)

Net cash from investing activities

(4,491)

66

(1,489)

Cash flows from financing activities

Net proceeds from new loan

2,641

-

1,500

Change in borrowings

(847)

(1,543)

(2,731)

Dividends paid

(1,038)

(944)

(1,460)

Net cash from financing activities

1,756

(2,487)

(2,691)

Increase in cash, cash equivalents and bank overdrafts

(894)

(1,630)

(345)

Cash and cash equivalents at 1 April

5,488

4,437

4,437

Overdraft at 1 April

(5,304)

(3,908)

(3,908)

Cash, cash equivalents and bank overdrafts

at 30 September and 31 March

 

(710)

 

(1,101)

 

184

Plastics Capital plc

Consolidated statement of changes in equity

 

Share

capital

Share

premium

Translation reserve

Reverse

acquisition

reserve

Capital redemption reserve

Retained

earnings

Total

£000

£000

£000

£000

£000

£000

£000

Balance at 31 March 2015

353

20,888

634

2,640

(200)

2,034

26,349

Profit or loss

-

-

(172)

-

-

634

462

Dividends paid

-

-

-

-

-

(944)

(944)

 

Balance at 30 September 2015

353

20,888

462

2,640

(200)

1,724

25,867

Profit or loss

-

-

177

-

-

588

765

Reserve correction

-

63

-

-

200

(263)

-

Dividend paid

-

-

-

-

-

(516)

(516)

Equity-settled share based payment transactions

-

-

-

-

-

207

207

Balance at 31 March 2016

353

20,951

639

2,640

-

1,740

26,323

Share issue

3

312

-

-

-

-

315

Profit or loss

-

-

13

-

-

(835)

(822)

Dividends paid

-

-

-

-

-

(1,038)

(1,038)

Balance at 30 September 2016

356

21,263

652

2,640

-

(133)

24,778

 

 

1 Basis of preparation and accounting policies

 

Basis of preparation

 

The interim financial information has been prepared on the basis of the recognition and measurement requirements of adopted IFRSs as at 30 September 2016 that are effective (or available for early adoption) as at 31 March 2017. Based on these adopted IFRSs, the directors have applied the accounting policies, as set out below, which they expect to apply to the annual IFRS financial statements for the year ending 31 March 2017.

 

However, the adopted IFRSs that will be effective (or available for early adoption) in the annual financial statements for the period ending 31 March 2016 are still subject to change and to additional interpretations and therefore cannot be determined with certainty. Accordingly, the accounting policies for that annual period will be determined finally only when the annual financial statements are prepared for the period ending 31 March 2017.

 

Accounting policies

 

The accounting policies applied to the Interim Results for six months ended 30 September 2016 are consistent with those of the Company's annual accounts for the year ended 31 March 2016.

 

Going concern

 

The Financial Reporting Council issued "Going Concern and Liquidity Risk: Guidance for Directors of UK Companies" in October 2009 and the Directors have considered this when preparing the financial statements. These have been prepared on a going concern basis and the Directors have taken steps to ensure that they believe the going concern basis of preparation remains appropriate.

 

 

2 Reconciliation of financial highlights table to the consolidated income statement

 

Unaudited

Six months to

30 September

2016

Unaudited

Six months to

30 September

2015

 

 

 

Change

£000

£000

%

Revenue

27,771

24,489

13.4%

Gross profit

8,877

7,520

18.0%

Operating profit

911

831

9.6%

Add back: Exceptional cost

269

222

Add back: Amortisation

749

703

Add back: Depreciation

802

708

EBITDA before exceptional costs

2,731

2,464

10.8%

(Loss) / Profit before tax

(728)

761

-195.7%

Add back: Amortisation

749

703

Add back: Exceptional costs

269

222

Add back: Capitalised deal fee amortisation

107

75

Add back: Unrealised foreign exchange & derivate losses/(gains)

1,240

(235)

Profit before tax*

1,637

1,526

7.3%

Taxation

(107)

(127)

Profit after tax*

1,530

1,398

9.4%

Basic adjusted EPS*+

4.3p

4.0p

7.3%

Basic EPS

(0.2)p

1.8p

(111.1)%

Capital expenditure

1,896

1,223

55.0%

Net Debt

15,123

11,864

27.5%

* excluding amortisation, exceptional costs, unrealised foreign exchange translation and unrealised derivative gains/losses

+ applying an expected tax charge of 6.5% and based on the average number of shares in issue in the year

 

3 Operating segment information

 

The following summary describes the operations in each of the Group's reportable segments:

· Films - includes industrial films

· Industrial - includes hose mandrel, creasing matrix and plastic bearings

 

 

Industrial

 

Films

Unallocated and reconciling items

 

Total

Unaudited

Six months to

30 September

2016

Unaudited

Six months to

30 September

2016

Unaudited

Six months to

30 September

2016

Unaudited

Six months to

30 September

2016

£000

£000

£000

£000

External sales*

12,455

15,316

-

27,771

(Loss) / profit before tax**

635

153

(1,516)

(728)

Depreciation and amortisation

471

303

777

1,551

_______

_______

_______

______

 

Unaudited

Six months to

30 September

2015

 

Unaudited

Six months to

30 September

2015

 

Unaudited

Six months to

30 September

2015

 

Unaudited

Six months to

30 September 2015

£000

£000

£000

£000

External sales*

10,503

13,984

-

24,487

Profit / (loss) before tax**

(124)

223

662

761

Depreciation and amortisation

438

264

709

1,411

_______

_______

_______

_______

Audited

Year to

31 March

2016

Audited

Year to

31 March

2016

Audited

Year to

31 March

2016

Audited

Year to

31 March

2016

£000

£000

£000

£000

External sales*

21,285

29,518

-

50,803

Profit / (loss) before tax**

645

1,055

(602)

1,098

Depreciation and amortisation

912

530

1,825

3,267

_______

_______

_______

_______

* All revenue is attributable to external customers, there are no transactions between operating segments

** Profit before tax for unallocated and reconciling items is analysed on Page 16.

 

3 Operating segment information (continued)

 

Reconciliation of reportable segment revenue

 

Unaudited

Six months to 30 September 2016

£000

 

Unaudited

Six months to 30 September 2015

£000

Audited

Year to

31 March

2016

£000

Films

High strength film packaging

15,316

13,984

29,518

Industrial

Packaging consumables

3,667

3,312

6,422

Plastics rotating parts

6,614

5,263

11,290

Hydraulic hose consumables

2,174

1,928

3,573

Turnover per consolidated income statement

27,771

24,487

50,803

 

 

Reconciliation of reportable segment profit

 

 

Unaudited

Six months to September 2016

£000

 

 

Unaudited

Six months to

30 September 2015

£000

 

 

Audited

Year to

31 March

2016

£000

Total profit for reportable segments

788

99

1,700

Unallocated amounts:

Amortisation

(749)

(703)

(1,819)

Unrealised (losses)/gains on derivatives

(1,240)

235

(7)

Management charge income

2,125

2,125

4,050

FX hedge (loss) on forward contracts

(307)

(142)

(239)

Plastics Capital Trading Ltd and Plastics Capital plc costs

(641)

(539)

(1,149)

LTIP charge

-

-

(401)

Net interest costs

(292)

(122)

(377)

Deal fee amortisation

(107)

(75)

(345)

Exceptional costs

(269)

(195)

(230)

Other

(36)

78

(85)

Consolidated (loss) / profit before income tax

(728)

761

1,098

 

 

4 Exceptional items

 

Administrative Expenses

 

Unaudited

Six months to 30 September 2016

£000

 

Unaudited

Six months to 30 September 2015

£000

Audited

Year to

31 March

2016

£000

Redundancy & recruitment costs

-

165

301

Acquisitions - professional and legal costs

269

-

120

Release of contingent consideration

-

-

(110)

Other

-

57

49

269

222

360

_____

 

 

5 Financial income and expenses

 

 

Unaudited

Six months to

30 September

2016

£000

 

Unaudited

Six months to

30 September

2015

£000

 

Audited

Year to

31 March

2016

£000

Financial expenses:

 Bank interest

292

230

377

 Amortisation of capitalised deal fees

107

75

345

 Loss on derivatives used to manage interest rate risk

-

-

-

Financial expenses

399

305

722

Financial income and expenses included within foreign exchange:

 Net foreign exchange (gains) / losses

-

(44)

31

 Unrealised losses on derivatives used to manage foreign exchange risk

1,240

279

7

Foreign exchange impact and derivatives

1,240

235

38

 

 

6 Taxation

 

The taxation charge is calculated by applying the Directors' best estimate of the annual tax rate for the profit for the period.

 

 

7 Dividends

 

The Directors recommend the payment of an interim dividend of 1.46p per share (30 September 2015: 1.46p).

 

 

 

8 Earnings per share

 

Unaudited

Six months to

30 September

2016

Unaudited

Six months to

30 September

2015

Audited

Year to

31 March

2016

£000

£000

£000

Numerator

(Loss) / profit for the period

(835)

634

1,222

Denominator

Weighted average number of shares used in basic EPS

34,512,663

35,344,573

34,463,255

Weighted average number of shares used in diluted EPS

36,665,359

35,444,573

36,005,262

Basic earnings per share (total)

(0.2)p

1.8p

3.5p

Diluted earnings per share (total)

(0.2)p

1.8p

3.4p

 

 

9 Accounts

 

Copies of the interim accounts may be obtained from the Company Secretary at the Registered Office of the Company: London Heliport, Bridges Court Road, London, SW11 3BE.

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR DGBDDDGGBGLS
Date   Source Headline
7th May 20247:00 amRNSUpdate on GOI Approval, Working Interest Transfer
9th Apr 20247:00 amRNSConversion of Loan Notes and TVR
2nd Apr 20247:00 amRNSAppointment of Executive Director
14th Mar 20247:00 amRNSInterim Financial Report
11th Mar 20247:00 amRNSFinancing Update
16th Feb 20247:00 amRNSResults of General Meeting
14th Feb 20242:27 pmRNSFinalisation of Cambay Field Farm Out and JV
31st Jan 20249:21 amRNSCambay Farm Out Update
25th Jan 20247:00 amRNSAddendum to the Notice of General Meeting
22nd Jan 20247:00 amRNSCambay Farm Out Update
15th Jan 20247:00 amRNSGM - Notice of Meeting
18th Dec 20238:05 amRNSCambay Farm Out and C-77H Update
18th Dec 20237:00 amRNSUpdate to Admission Date
5th Dec 20237:00 amRNSCambay Farm-Out and Funding Arrangements & TVR
16th Nov 20237:00 amRNSResults of Annual General Meeting
3rd Nov 20237:05 amRNSCambay C-77H Artificial Lift Update
23rd Oct 20238:38 amRNSAGM - Notice of Meeting
25th Sep 202312:48 pmRNSCambay C-77H Workover Update
21st Sep 20237:00 amRNSAnnual Report 2023
14th Sep 20237:00 amRNSInvestor Presentation
8th Sep 20237:00 amRNSChange of Company Secretary
23rd Aug 20239:05 amRNSCambay C-77H Workover Update
8th Aug 202311:32 amRNSPlacement – Issue of Securities and TVR
26th Jul 20237:00 amRNSCambay C-77H Workover Update
25th Jul 202310:52 amRNSCambay C-77H Workover Funding Secured and TVR
4th Jul 20237:00 amRNSCambay C-77H Artificial Lift Update
29th Jun 20237:00 amRNSAppointment of Joint Broker / Board Amendments
27th Jun 202310:17 amRNSUK CCS License Applications
1st Jun 20237:00 amRNSCambay C-77H Artificial Lift Update
18th May 202312:27 pmRNSUK CCS License Applications
28th Apr 20237:00 amRNSChange of Registered Office
26th Apr 20233:35 pmRNSUpdate on Farm Out Process
13th Apr 20237:00 amRNSCambay Update
4th Apr 20237:00 amRNSIssue of Options
15th Mar 20237:00 amRNSInterim Financial Report
9th Mar 20237:00 amRNSCambay C-77H Artificial Lift Update
27th Feb 20237:00 amRNSCambay Farm Out and CCS Update
23rd Feb 20234:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20232:05 pmRNSSecond Price Monitoring Extn
23rd Feb 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20237:00 amRNSConvertible Loan Agreement
1st Feb 20237:00 amRNSCambay C-77H Update
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn
30th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSCambay CCS Scheme Presentation
23rd Dec 20227:00 amRNSUpdate - Removal from the Official List of the ASX
13th Dec 20227:00 amRNSShareholder Presentation
1st Dec 20227:00 amRNSCambay PSC Update
29th Nov 202212:50 pmRNSUpdate - Formal request for removal from ASX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.